BRNS
Barinthus Biotherapeutics plc
NASDAQ · Healthcare · Biotechnology · GB
$0.76
+5.50%Next report
Analyst consensus
- Next report date
- Nov 6, 2026
- EPS estimate
- -$0.27
- Revenue estimate
- $216.9K
Latest reported
- Last report date
- Aug 6, 2026
- EPS actual
- -$0.26
- EPS estimate
- -$0.28
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 6
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +27.5%
- Revenue beats (12Q)
- 1
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 6, 2026